Ventricular Assist Devices and Chronic Kidney Replacement Therapy: Technology and Outcomes. Adv Chronic Kidney Dis 2021 Jan;28(1):37-46
Date
08/15/2021Pubmed ID
34389136DOI
10.1053/j.ackd.2021.01.002Scopus ID
2-s2.0-85112321788 (requires institutional sign-in at Scopus site) 1 CitationAbstract
Heart failure and kidney failure are very common conditions, precipitating and exacerbating each other. Left ventricular assist devices (LVADs) represent a relatively new technology for treatment of advanced heart failure. Kidney dysfunction, if present, makes candidate selection for LVADs challenging and contributes to multiple complications while the patients are on an LVAD support. Although kidney function generally improves after LVAD implantation, some patients develop acute and then chronic kidney disease sometimes requiring kidney replacement therapies (KRTs). Overall, chronic KRT in LVAD recipients is feasible and well tolerated, but routine technique of blood pressure monitoring should be adjusted to the continuous blood flow. Both hemodialysis and peritoneal dialysis can be used. Unique challenges for chronic KRT posed by the presence of LVAD are discussed in this review.
Author List
Jawaid O, Gaddy A, Omar HR, Guglin MAuthor
Anna Gaddy MD Assistant Professor in the Medicine department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
Heart FailureHeart-Assist Devices
Humans
Renal Insufficiency, Chronic
Renal Replacement Therapy
Technology
